Vancouver-based Absci to send first drug to clinical trials in what CEO calls a ‘huge milestone’ The Citizen 8 months ago Absci is preparing to send its first internally developed drug to clinical trials. Read more… Source: The Columbian Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Click to share on Pinterest (Opens in new window) Pinterest Click to share on WhatsApp (Opens in new window) WhatsApp
